Results 31 to 40 of about 11,689 (208)
Vaccines, 2022 At the start of the SARS-CoV-2 pandemic, healthcare workers had an increased risk of acquiring coronavirus disease (COVID)-19. As tertiary care hospitals are critical for the treatment of severely ill patients, the University Hospital Erlangen offered ...
Valentin Niekrens +7 more
doaj +1 more source
Typhoid VI: A Less Reactogenic Vaccine
Journal of International Medical Research, 1992 A typhoid vaccine derived from the purified Vi capsular polysaccharide (CPS) antigen of Salmonella typhi was compared with a heat-killed whole-cell typhoid vaccine in 637 healthy male volunteers. The individuals were placed in three groups: group 1 received two doses of heat-killed whole-cell typhoid vaccine, at an interval of 28 days; group 2 received
N S, Cumberland +4 more
openaire +2 more sources
Human Vaccines & Immunotherapeutics, 2023 We conducted a dose-finding phase 2 study of the HilleVax bivalent virus-like particle (VLP) vaccine candidate (HIL-214) in two cohorts of children, 6–≤12 months and 1–≤4 years of age (N = 120 per cohort), in Panama and Colombia (ClinicalTrials.gov ...
Pio López +8 more
doaj +1 more source
Vaccines, 2021 Vaccinations are a key prevention measure in fighting the COVID-19 pandemic. The BNT162b2 mRNA vaccine (BioNTech/Pfizer), the first to receive authorization, was widely used in the mass vaccination campaign in Italy. Healthcare workers were identified as
Alborz Rahmani +14 more
doaj +1 more source
Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
Human Vaccines & Immunotherapeutics, 2023 As global supply is still inadequate to address the worldwide requirements for HPV vaccines, we assessed the safety and immunogenicity of a new bivalent HPV16/18 vaccine.
Li-Wei Shi +16 more
doaj +1 more source
Vaccines, 2022 The recent emergence of new variants of concern (VOCs) of SARS-CoV-2 and the uncertain duration of protection provided by the primary immunization cycle have highlighted the need for COVID-19 booster vaccinations.
Alborz Rahmani +14 more
doaj +1 more source
Vaccines, 2022 In a previous study, we described a highly significant association between reactogenicity and SARS-CoV-2 RBD IgG titers and wild-type neutralization capacity in males after basic vaccination with BNT162b2.
Stilla Bauernfeind +9 more
doaj +1 more source
Diphtheria and tetanus vaccine: a comparative study of reactogenicity
International Journal of Clinical Practice, 1989 One hundred and eighty children aged between four and six years were intensively followed-up after receiving diphtheria/tetanus vaccine. A daily diary was used as the method of assessment to elicit as many transient effects as possible. The results confirm the predicted profile of these vaccines with a high incidence of local effects but little general
K A, Bryett +3 more
openaire +2 more sources
Editorial: Non-reactogenic vaccines against Q-fever
Frontiers in Immunology, 2023 Anthony E. Gregory, D. Huw Davies
doaj +3 more sources
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis [PDF]
Neurology Neuroimmunology & Neuroinflammation, 2022 There are limited data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine reactogenicity in persons with multiple sclerosis (PwMS) and how reactogenicity is affected by disease-modifying therapies (DMTs). The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis-specific vaccine safety ...
Farren Basil Shaw Briggs +13 more
openaire +2 more sources